Connect with us

Hi, what are you looking for?

Tech News

L’Oréal’s new skincare gadget told me I should try retinol

The Cell BioPrint is designed to be used in retail spaces and dermatology offices. | Photo by Victoria Song / The Verge

Las Vegas is punishingly dry. The arid winter air means I woke up on Day 3 of CES 2025 with a nosebleed, chapped lips, and ashy legs. This in spite of the fact I slathered myself with two pumps of a fermented bean essence, eye cream, moisturizer, and a lip mask. Staring at my face in the hotel mirror, I wonder if any of those products were doing what they’re supposed to — and if maybe, I should try something different.

This is why I was so eager to try L’Oréal’s Cell BioPrint.

For anyone who’s struggled with their complexion, the Cell BioPrint feels like a holy grail gadget. The device is a mini-lab setup that analyzes a skin sample to generate a report about your skin’s current condition. It’ll also “grade” your skin with regard to oiliness, wrinkles, skin barrier function, pore size, and uneven skin tone. Based on the proteins in your skin, you’ll also see whether you’re more likely to be susceptible to those issues down the line — even if they aren’t issues now. The test also determines whether you’re responsive to retinol, a popular and well-studied skincare ingredient that nevertheless causes a ton of confusion online.

Photo by Victoria Song / The Verge

Read the full story at The Verge.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Investing

Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is a Canadian-incorporated mineral exploration and development company whose principal business objective is to...

Politics

As President Biden meets with Chinese President Xi Jinping on Wednesday, the House select committee examining the United States’ relationship with China is set...

Stock

Shopify (SHOP) share value jumped by over 20% Thursday morning after stunning analysts with a sharp earnings beat and rosy guidance. The stock reached...

Politics

In the weeks after the 2020 election, an obscure Republican lawmaker from Louisiana led a congressional effort to overturn the presidential results in four...